RxDoctor Payments Data

Paul Brezinski

Podiatrist · Palatine, ILNPI 1962513804

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $461 and has fallen 69.8% since, to $139 in 2025.

$1,051in general payments, 2019–2025

Across 18 payments — averaging $58.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Royal Biologics, Inc.$119
  • Fusion Orthopedics USA, LLC$109
  • Tactile Systems Technology Inc$106
  • Amgen$98
  • Paratek Pharmaceuticals, Inc.$98
  • Medline Industries LP$94
  • plus $425 from 10 others

What the payments were for

  • Food & beverage$1,051100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,051 in reported general payments places this provider in the 55th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois →

Medicare billing

Part B allowed, 2024
$55,519
Medicare patients
162
Services billed
942

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone36$206

Paid to pharmacies, not to this prescriber.

Other podiatrist in Palatine

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →